According to the latest report by IMARC Group, titled “Cervical Cancer Diagnostics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global cervical cancer diagnostics market size reached a strong growth in 2020. Cervical cancer diagnostics includes a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells of the human papillomavirus (HPV). They are conducted by taking a sample of the tissue obtained through punch biopsy, endocervical curettage, conization, and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, several tests, including blood, CT scan, MRI, PET scan, and visual examination of bladder and rectum, are performed to determine the disease stage.
Request Free Sample Report: https://www.imarcgroup.com/cervical-cancer-diagnostics-market/requestsample
A significant rise in the number of individuals diagnosed with sexually transmitted infections (STIs), including syphilis, chlamydia, gonorrhea, etc., is escalating the risk of HPV infection. Furthermore, with the rising awareness towards the early diagnosis and treatment of cervical cancer, several individuals are adopting HPV home testing kits that provide quick and accurate test results. Besides this, the wide availability of various treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy, and trachelectomy, is also propelling the global market for cervical cancer diagnostics. Looking forward, IMARC Group expects the global cervical cancer diagnostics market to continue its moderate growth during 2021-2026.
Breakup by Test Type:
- Pap Testing
- HPV Testing
- Cervical Biopsies
Breakup by Age Group:
- 20 to 35 years
- Above 35 years
Breakup by Region:
Competitive Landscape with Key Player:
- Abbott Laboratories
- Arbor Vita Corporation
- Dickinson and Company
- Cooper Surgical Inc.
- F. Hoffmann-La Roche AG
- Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/cervical-cancer-diagnostics-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want to need latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Other Reports by IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Address:30 N Gould St Ste R Sheridan
Country: United States